Zubsolv Clinical Trial

Pharmacy Medical Necessity Guidelines: Opioid Dependence ...
Pharmacy Medical Necessity Guidelines: Opioid Dependence Medications Effective: November 11, 2015 Clinical Documentation and Prior Authorization Required √ Type of Review – Care Management Not Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am ... Read Full Source

Provider Synergies, An Affiliate Of Magellan Medicaid ...
Provider Synergies, an affiliate of Magellan Medicaid Administration, ZubsolvTM 68 / 34 days ***Clinical Criteria for naltrexone (oral) Must have a diagnosis of : Trial and therapeutic failure of all preferred drugs ... Access Content

GEHA 1-888-836-0730 1-855-240-0536
Zubsolv (buprenorphine- naloxone) TRIAL YEAR AND REASON FOR FAILURE) Y . N : 2016 . 3. Does the patient have a documented clinical reason such as expected adverse reaction or contraindication that prevents them from trying the formulary alternatives listed below? ... Read Here

Criteria, Step Therapy, And Quantity Limits For TennCare ...
Clinical Criteria, Step Therapy, and Quantity Limits for TennCare Preferred Drug List (PDL) January 1, 2016 ANALGESICS Approval of NP agents requires trial and failure, contraindication or intolerance of 2 preferred agents, unless otherwise indicated. Medication PDL Prior ... Doc Retrieval

Amerikanska FDA Godkänner Zubsolv® För Initiering Av ...
Amerikanska FDA godkänner Zubsolv® för initiering av (Induction, STabilization, Adherence and Retention Trial, studie OX219-006), och av studie OX219- (Clinical Opiate Withdrawal Scale, COWS, Subjective Opiate Withdrawal Scale, ... Read Content

Montana Medicaid Preferred Drug List (PDL) Revised 11/9/2015
Montana Medicaid Preferred Drug List (PDL) Revised 11/9/2015 Zubsolv®% % Clinical criteria applies ¶Physician Administered ANTI-INFECTIVES Trial of 2 preferred agents required . Montana Medicaid Preferred Drug List (PDL) ... Return Document

Buprenorphine - Wikipedia, The Free Encyclopedia
Suboxone, Zubsolv, Bunavail (available as buprenorphine HCl alone or A clinical trial conducted at Harvard Medical School in the mid-1990s demonstrated that a majority of unipolar non-psychotic persons with major depression refractory to conventional antidepressants and ... Read Article

Provider Synergies, An Affiliate Of Magellan Medicaid ...
Virginia Medicaid Prefer red Drug List With Service Authorization Criteria Effective January 1, 2014 1 Provider Synergies, an affiliate of Magellan Medicaid Administration , ... Access Doc

Effects Of A Higher-bioavailability ... - Clinical Therapeutics
Clinical Therapeutics/Volume 37, Number 10, 2015 Effects of a Higher-bioavailability Buprenorphine/Naloxone Sublingual Tablet Versus Buprenorphine/Naloxone Film for ... Access Doc

Therapeutic Class Overview Buprenorphine And Buprenorphine ...
Therapeutic Class Overview . Buprenorphine and Buprenorphine/Naloxone . Zubsolv sublingual tablets [package insert]. New York (NY): dependence: a multicenter, randomized clinical trial. Addiction. 1998;93(4):47586.- 29. ... View This Document

UPMC Health Plan
Please submit documentation showing why the member cannot use the Suboxone film or Zubsolv tablet. Please include clinical information showing an adequate trial of Suboxone film with an inadequate response or intolerance. ... Get Content Here

First Patient Dosed In A New Clinical Study Designed To ...
Press release . First Patient Dosed in a New Clinical Study Designed to Assess Early Treatment Efficacy and Acceptability of Zubsolv® Uppsala, Sweden – August 7, 2013 – Orexo AB announces that the first patient has been ... Doc Viewer

Full Year Report January-December 2014 - Orexo.com
The clinical trial comparing Zubsolv with our leading competitor, the ISTART study, was especially important. The study confirmed the patient preference for Zubsolv and that the two products have a similar clinical effect. ... Retrieve Content

Pharmacy Medical Necessity Guidelines: Opioid Dependence ...
Clinical Documentation and Prior Authorization Required √ Type of Review Zubsolv, and Bunavail multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry. 2011 Nov; 50(11) ... Retrieve Here

2013-10-09 P&T Minutes - Medicaid.ohio.gov
Ms. Scott presented the proposed clinical criteria, attached to the minutes. determine an appropriate length of trial for the preferred product. The committee vote was unanimous to place Zubsolv in non-preferred status, ... Fetch Content

Orexo Preliminary Results - Baystreet.ca
Orexo is a research client of Edison Investment Research Limited Zubsolv has captured 1.9% market share (by volume) in the first 18 weeks Zubsolv clinical data at ASAM 10-13 April 2014 Q114 results 25 April 2014 Launch of potential line extensions Q314 . ... Read Full Source

Provider Synergies, An Affiliate Of Magellan Medicaid ...
Virginia Medicaid Preferred Drug List With Service Authorization Criteria Effective January 1, 2014 1 Provider Synergies, an affiliate of Magellan Medicaid Administration, ... Return Doc

Orexo Initiation Of Coverage - Baystreet.ca
Orexo’s investment case centres on the commercial success of Zubsolv, a sublingual tablet for the maintenance treatment of opioid dependence. outcome of pricing reviews and new clinical data, Phase III induction trial is positive; clinical differentiation would support a premium ... Content Retrieval

Therapeutic Class Overview Opioid Dependence Agents
Zubsolv ®) and naltrexone Therapeutic Class Overview: Opioid Dependence Agents Page 3 of 4 controlled clinical trial. J Subst Abuse Treat. 2004 Jul;27(1):75-82. 42. Minozzi S, Amato L, Davoli M. Detoxification treatments for opiate dependent adolescents. ... Get Doc

Buprenorphine/Naloxone Products (Bunavail, Suboxone Film ...
Buprenorphine/Naloxone Products (Bunavail, Suboxone Film, Generic Buprenorphine/Naloxone): Clinical Policy (Effective 09/01/2015) ©1996-2015, Oxford Health Plans, LLC 1 inadequate response to a minimum 30-day trial of Zubsolv. ... Content Retrieval

MEDICAL POLICY STATEMENT - CareSource
MEDICAL POLICY STATEMENT supported by clinical guidelines, nationally recognized utilization and technology assessment guidelines, other medical managment e • A trial and failure of a generic Buprenorphine agent must occur before Suboxone Film or ... Retrieve Doc